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The novel and potential chelating agent derived from Nalidixic acid and its binary Cu(II), Ni(II) and Co(II) metal 
complexes have been synthesized and characterized by elemental analyses, 1H-NMR, Mass, UV-vis, FT-IR, TGA, SEM-
EDX, ESR and magnetic susceptibility measurements. All the systems of the present study have been screened for 
antimicrobial activity against bacterial species Bacillus (Gram +) and Escherichia coli (Gram ) and fungal species 
Sclerotium rolfsii and Macrophomina phaseolina exhibited an enhanced activity of metal complexes over unbound free 
chelating agent. The interaction studies of metal complexes with Calf-thymus DNA (CT-DNA) investigated by UV-visible 
and fluorescence titrations revealed the intercalation mode of binding. Further MTT assay performed on HeLa (human 
cervical cancer) and A549 (human lung tumor) cell lines revealed the IC50 values for the studied title compounds. In addition 
computer-aided molecular docking technique carried out with all title compounds employing molecular target DNA (PDB 
ID: 1N37), furnished docking scores and mode of binding for geometry optimized molecular structures of title compounds.  
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Hydrazones and their transition metal complexes have 
attained much importance in inorganic and medicinal 
chemistry in view of their diverse biological and 
pharmacological activities1. In general the role of 
transition metal complexes has been found to be 
essential to reveal the complexity in biology2. The 
interaction of transition metal complexes with DNA 
has been extensively studied in the past few years due 
to their possible applications in molecular biology and 
cancer therapy3-11. DNA being the primary target 
molecule for most antiviral and anticancer therapies, 
the binding mode of interaction between a novel 
transition metal complex and DNA has been a subject 
of basic research in bioinorganic chemistry in recent 
years12-15. Basically, metal complexes bind to DNA 
double helix via non-covalent modes including 
intercalative, external electrostatic and groove 
binding16-19 or covalent modes, a proper 
understanding of which, could be critical for 
explaining DNA. Among them the intercalative 
binding mode is significantly important as it results in 
the formation of more stable DNA-metal complex 
adduct. Molecular recognition has a central role in 
rational drug design20. Binding affinity and 
interactions are two key components which aid to 
understand the molecular recognition in drug-receptor 
complex and are crucial for structure-based drug 
design in medicinal chemistry21. The choice of metal 
ion is the most significant factor in the design of 
metal based chemotherapeutic agents22. There has 
been growing interest in the investigation of Cu(II), 
Co(II) and Ni(II) metal complexes for their interaction 
with DNA23-28 as is evident from literature29-35. Such 
complexes exhibit antibacterial, antifungal, anti-
cancer and cancer inhibiting properties.  
In the present investigation, some transition metal 
complexes of novel Nalidixic acid hydrazone were 
synthesized keeping in view the significant biological 
activity of its precursor nalidixic acid and its metal 
complexes reported earlier36. The spectroscopic 
characterization of synthesized novel nalidixic acid 
hydrazone; [N’-(2-hydroxy-5-nitrobenzylidene)-1-
ethyle-1,4-dihydro-7-methyle-4-oxo-18-naphthyridine 
-3-carbohydrazone (NTEMNC)] and its solid Cu(II), 
Ni(II) and Co(II) metal complexes and the evaluation 
of their antimicrobial activity, DNA interaction, 
cytotoxicity and docking studies have been reported 
herein. 
 
Materials and Methods 
Calf-thymus DNA (CT-DNA) (50 μg/test) was 
purchased from Bangalore genei. HeLa (Cervical 




cancer cell line) and A549 (human lung tumor cell 
line) were purchased from NCCS, Pune. MTT  
[3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide], DMEM (Dulbecco's modified Eagles 
medium), EDTA and Phosphate Buffered Saline 
(PBS) were purchased from Sigma Chemicals and 
Fetal Bovine Serum (FBS) was purchased from 
Gibco. Nalidixic acid and all other chemicals were 
purchased from Sigma Aldrich. 
UV-Visible spectra were recorded with a  
Shimadzu UV-2600 Spectrophotometer. Fluorescence 
measurements were performed on a JASCO FP-8500 
Spectrofluorimeter. The IR spectra were recorded on 
KBr disks on Shimadzu IR Prestige-21 
Spectrophotometer. 1H-NMR spectra were recorded 
on a Bruker WH (400 MHz) Spectrometer with 
CDCl3 as solvent. Thermal analyses were carried out 
using Shimadzu TGA-50H in nitrogen atmosphere; 
SEM images were recorded in INCA EDX analyzer. 
The elemental analyses of compounds under study 
were carried out on atomic absorption 
spectrophotometer (ELICO-SL 163). ESI-MS mass 
spectra were recorded on VG AUTOSPEC mass 
spectrometer. Magnetic properties of metal complexes 
have been determined on a Gouy balance model 7550 
at room temperature using Hg [Co(SCN)4] as 
standard. ESR spectra were scanned on JES - FA200 
ESR Spectrometer with X band at 77 K (liquid 
nitrogen temperature). Melting points were 
determined in Polmon apparatus (model no. MP-90).  
Synthesis of nalidixic acid hydrazone [N’-((2-
hydroxy-5-nitrobenzylidene)-1-ethyl-1, 4-dihydro-7-
methyl-4-oxo-1, 8-naphthyridine-3-carbohydrazide 
(NTEMNC)] involves three steps37.  
Step-I: Synthesis of nalidixic acid ester: Nalidixic 
acid (3 g) and tetrahydrofuran (100 mL) were taken in 
a 250 mL round bottom flask and mounted over a 
magnetic stirrer. Anhydrous potassium carbonate 
(8.96 g) was added and the contents were stirred for  
1 h. Dimethyl sulfate (2.475 mL) was added to this 
stirred solution and the mixture was refluxed at  
60–80 °C. The progress of the reaction was monitored 
by TLC using hexane/ethyl acetate (70:30) as the 
eluent. After 6 h, a new spot was observed on the 
TLC plate. After the completion of reaction, the 
solvent was removed under reduced pressure using a 
rotary evaporator and the product was extracted with 
chloroform. The chloroform layer was dried over 
anhydrous sodium sulfate and concentrated under 
reduced pressure to give the desired ester.  
Step-II: Synthesis of nalidixic acid hydrazide: The 
above synthesized ester (2 g) was dissolved in 
tetrahydrofuran (60 mL) in a 250 mL round bottom 
flask and hydrazine hydrate (NH2NH2.H2O, 0.8 mL) 
was added. The contents were refluxed for 3 h. To the 
resultant reaction mixture, cold water (100 mL) was 
added and the mixture stirred for 30 min. The 
separated solid was filtered using a pump and dried. 
Step-III: Synthesis of nalidixic acid hydrazone 
(NTEMNC): The above prepared hydrazide (0.1 mol) 
and 2-hydroxy-5-nitrobenzaldehyde (0.1 mol) were 
dissolved in methanol (50 mL). The mixture was 
refluxed at 60–70 °C on a magnetic stirrer for 2–3 h. 
The progress of the reaction was monitored by TLC. 
After completion of the reaction, the product was 
cooled to room temperature. The solid obtained was 
filtered and washed with methanol and recrystallized 
from aqueous ethanol to obtain pure compound (m.pt 
310 °C) (Scheme 1). The metal complexes were 
prepared by refluxing the solution of hydrazone 
(NTEMNC) dissolved in chloroform and 
corresponding Cu(II)Cl2.6H2O, Ni(II)Cl2.6H2O and 
Co(II)Cl2.6H2O metal salts in ethanol (1:2 mol) for 
15–18 h at 60–80 °C and by adjusting pH in the range 
6.5–7.5 for complex formation. The resulting 
solutions were concentrated and cooled. On cooling, 
the colored metal complexes obtained were filtered 
and washed several times with ethanol and 
chloroform. These were then dried and stored in 
desiccators over anhydrous CaCl2.  
In the present investigation AutoDock 4.2 
software38 was employed to carry out molecular 
docking studies of the synthesized hydrazone and its 
metal complexes with the DNA target. In order to 
carry out molecular docking with DNA, crystal 
structure of double stranded DNA molecule 
(AGACGTCT)2 (PDB ID: 1N37) was downloaded 
from protein data bank (www.rcsb.org)39. It was 
prepared by protein preparation wizard applying 
OPLS 2005 force field in Schrödinger suite. A grid 
was prepared around the intercalation site by selecting 
the co-crystallized ligand. Metal complexes were 
constructed and optimized in ChemDraw. These were 
docked into DNA intercalation site and molecular 
interaction diagrams were obtained from PMV 
(Python Molecular Viewer) 40. 
Absorption studies were recorded on a 
Shimadzu160A UV-visible spectrophotometer. 
Absorption titration experiments were performed with 
a fixed concentration of metal complex (5 µM) and by 




varying the concentration of CT-DNA (0–5 µM) 
according to the reported procedure41. The titration 
was continued until there was no change in 
absorbance which indicates the saturation point for 
binding. For the complexes Cu(II), Ni(II) and Co(II), 
the binding constants (Kb), were determined from the 
spectroscopic titration data using the following 
equation: 
 
[DNA]/ (a − f) = [DNA]/ (b − f) + 1/Kb (b − f) … (1) 
 
The apparent absorption coefficient a, corresponds 
to Aobs/[metal complex] in the absence of DNA. In 
presence of DNA, the terms f and b correspond to 
the extinction coefficient of the free metal complex 
(unbound) and the fully bound metal complex to 
DNA respectively42. 
The binding of metal complexes to CT-DNA was 
also studied by fluorescence technique. Fluorescence 
study was performed on a JASCO FP-8500 
spectrofluorimeter. The change in fluorescence 
intensity at 605 nm was recorded by adding the 
solution of metal complex in small increments, to the 
mixture of ethidium bromide (EB) (36 µM) and DNA 
(36 µM).  
The fluorescence quenching is described by the 
Stern-Volmer relation43: 
 
I0/I = Ksv [r] +1  … (2) 
 
where I0 and I represent the fluorescence intensities 
in the absence and presence of the quencher, 
respectively. Ksv is a linear Stern-Volmer quenching 
constant, and [r] is the quencher concentration. The 
quenching constant (Ksv) can be obtained using the 
plot of log (I0/I) versus [r]. 
For a static quenching interaction, the fluorescence 
intensity data can also be used to determine the 
apparent binding constant (Kq) and the number of 
binding sites (n) for the complex by the following 
equation44: 
 
log [F0− F/ F] = log Kb+ n log [Q] … (3) 
 
From the plot of log [(F0 − F/F)] versus log [Q], the 
binding stoichiometry (n) has been obtained from the 
slope and binding constant (Kb) from intercept value. 
The synthesized hydrazone and its Cu(II), Ni(II) 
and Co(II) complexes with different concentrations 
(25, 50 and 100 µM) were screened for the in vitro 
antibacterial activity with Gram-positive bacteria 
(Bacillus) and Gram-negative bacteria (Escherichia 
coli) and antifungal activity against two fungi species 
(Macrophomina phaseolina and Sclerotium rolfsii) by 
using standard procedure45.  
The in vitro anticancer activity was measured  
using the 3-(4,5-dimethylthiazol-2-y1)-2,5-
diphenyltetrazolium bromide (MTT) assay46. HeLa 
(human cervical cancer cell line) and A549 (human 
 
 




lung tumor cell line) were maintained in Dulbecco's 
Modified Eagle's medium (DMEM), supplemented 
with 10% Fetal Bovine Serum (FBS) and the 
antibiotics penicillin/streptomycin (0.5 mL-1), in an 
atmosphere of 5% CO2/ 95% air at 37 °C. Cell 
viability was evaluated by the MTT assay with three 
independent experiments with 10, 25, 50, 75 and  
100 µM concentration of compounds in triplicates. 
Cells are trypsinized and the trypan blue assay is 
performed to know viable cells in cell suspension. 
Cells are counted by haemocytometer and seeded at a 
density of 5.0×103 cells /well in 100 μL media in 96 
well plate culture medium and incubated overnight at 
37 °C. After incubation, the old medium is removed 
and 100 µL of fresh medium and different 
concentrations of the test compound are added into 
representative wells of 96 plates, and then incubated 
for 48 h. After 48 h, the MTT solution (0.5 mg/mL) 
was added to each well and plates were incubated at  
37 °C for 3 h. At the end of incubation time, the 
precipitate forms as a result of reduction of MTT salt to 
chromophore formazan crystals by the cells with 
metabolically active mitochondria. The optical density 
of solubilized crystals in DMSO was measured at  
570 nm on a microplate reader. The percentage growth 
inhibition was calculated and concentration of test drug 
needed to inhibit cell growth by 50% values was 
generated from the dose-response curves for each cell 
line using linear regression equation47.  
 
Results and Discussion  
 
Spectral studies of NTEMNC 
 
Mass and elemental analyses 
The mass spectrum of ligand (NTEMNC) 
displayed (Supplementary Data, Fig. S1) a peak at  
m/z 395, that corresponds to the molecular ion peak. 
Elemental analyses (Found: C 57.70; H 4.10; N 17.90; 
Calcd: C 57.72; H 4.03; N 17.71 %) indicated the 
composition of title compound as C19H17N5O5. 
 
1H- NMR 
The 1H-NMR spectrum of NTEMNC showed  
(Fig. S2) a signal at δ 13.40 ppm corresponding to 
amide proton (s, NH). The signal at δ 10.01 ppm is  
(s, -CH=N-) attributed to azomethine proton and the 
peak at δ 11.60 ppm (s, OH) to phenolic OH which is 
further identified with D2O exchange spectrum  
(Fig. S3). The other signals were recorded at δ  
8.68 ppm (s, 1H, H-2-napthyridine), δ 8.98 ppm  
(d, 1H, H-5-napthyridine), δ 8.42 ppm (d, 1H,  
H-6-napthyridine), δ 7.07–8.18 ppm (m, 3H, 
aromatic), δ 4.60 ppm (q, 2H, N-CH2 ), δ 1.56 ppm  
(t, 3H, N-CH2 CH3), and δ 2.71 ppm (s, 3H, 7-CH3).  
 
Infrared spectral studies 
IR spectrum of NTEMNC showed the presence of 
a broad band centered at (Fig. S4) 3493 cm-1 
attributed to phenolic ν (OH) and amide ν (N-H) 
group stretching vibrations. The small intense bands 
noticed at 3039 cm-1 and 2983 cm-1 are due to 
aromatic ν (C-H) and aliphatic ν (C-H) stretching 
vibrations. The strong intense bands at 1612 cm-1 and 
1680 cm-1 correspond to the quinolone ring ν (C=O) 
stretching vibrations. The spectrum also showed 
bands at 1570 cm-1 , 1292 cm-1 and 1340 cm-1 
corresponding to azomethine ν (C=N), phenolic ν  
(C-O) and ν (N=O) stretching vibrations respectively. 
 
UV-Visible spectral studies 
The spectrum showed (Fig. S5) three bands at  
267 nm (37453.18 cm-1), 292 nm (34246.58cm-1) and 
323 nm (30959.75 cm-1) corresponding to the n→ π* 
transition of the C=O and n→ π* transitions of the 
C=N group. 
 
Characterization of metal complexes 
The metal complexes of the present investigation 
were characterized with the data obtained from 
various analytical and spectral techniques viz., 
elemental analyses, mass, IR, UV-vis, TGA, SEM, 
EDX, ESR and measurement of magnetic 
susceptibilities.  
All the metal complexes are colored, amorphous in 
nature and soluble in DMSO. Conductivity 
measurements made in DMSO medium, indicated 
their non-electrolytic nature.  
 
Mass and elemental analyses  
The mass spectral peaks displayed (Fig. S6, S7 and 
S8) at m/z 851, 846 and 847 in Cu(II), Ni(II) and 
Co(II) complexes respectively and the results 
obtained from elemental analyses presented in  
Table 1, showed metal to ligand ratio as 1:2 (M:2L) in 
all the aforementioned complexes. 
 
Infrared spectral studies 
The IR spectra provided valuable information 
about the type of donor sites attached to the metal ion 
in a complex. The IR spectrum of the ligand is 
compared with the IR spectra of its Cu(II), Ni(II) and 
Co(II) metal complexes (Fig. S9). All the metal 
complexes showed a new broad band in the region 
3400–3592 cm-1 which can be attributed to ν (OH) of 
coordinated water molecules48 and two weaker bands 
in the region 820–840 cm-1 and 710–760 cm-1 49 due 
to rocking and wagging modes of vibrations. The  




–CH=N stretching frequency in the IR spectrum of 
ligand observed at 1570 cm-1 is shifted towards lower 
frequency (1544, 1527 and 1530 cm-1) in Cu(II), 
Ni(II) and Co(II) metal complexes respectively 
indicating the participation of (–CH=N) nitrogen (N) 
in coordination with the metal (II) ion with the 
donation of lone pair of electrons having slight 
bonding character 50. The phenolic ν (C-O) band is 
shifted from 1292 cm-1 to the region of  
1230–1247 cm-1 51 in all metal complexes, indicating 
the participation of phenolic oxygen (O) in metal-
oxygen bond formation. In addition, new bands around 
430–475 cm-1 and 550–596 cm-1 in all complexes, 
correspond to ν (M-N) and ν (M-O) 52 respectively.  
 
Electronic spectral studies  
The electronic spectrum of free ligand (NTEMNC) 
and its metal (II) complexes were recorded in DMSO 
solution (10-3 M) in the range of 200–800 nm. The 
complexes exhibited (Fig. 1) distinct electronic 
transitions, which may be attributed to spin and 
vibronically allowed d-d transitions under respective 
stereochemistries, wherein Cu(II) complex displayed 
bands at 700 nm (14285.71 cm-1), 472 nm  
(21186.44 cm-1) and 405 nm (24691.36 cm-1), Ni(II) 
complex at 701 nm (14265.34 cm-1) and 447 nm 
(22371 cm-1), and, Co(II) complex at 703 nm 
(14224.75 cm-1) and 400 nm (25000 cm-1) .  
 
SEM and EDX studies 
The SEM images of ligand and its Cu(II), Ni(II) 
and Co(II) complexes displayed (Fig. S10–S13) 
distinct morphology. The EDX analyses of all metal 
complexes revealed the elemental composition 
wherein absence of chlorine is evident, thus 
confirming the binding of metal ion with mono-
ionized form of ligand in 1:2 ratio (M:L2) by the 
displacement of two chloride ions from metal salt. 
 
Thermal studies 
Thermogravimetric analysis (TGA) is a useful 
technique in evaluating the thermal stability of the 
metal complexes. The thermal analyses of Cu(II), 
Co(II) and Ni(II) complexes were carried out at a 
heating rate of 10 °C min−1 under nitrogen 
atmosphere. Thermograms of Cu(II), Co(II) and 
Ni(II) complexes are given in Fig. 2. The results 
obtained suggested that all metal complexes exhibit 
distinct decomposition process mainly in three stages. 
The first stage of decomposition in the range of  
120–210 °C corresponds to the loss of two coordinated 
water molecules. In the second step, a sudden weight 
loss in the range of 245–410 °C and then gradual loss 
up to 1000 °C, indicates the decomposition of ligand 
moiety. The percentage of final residue remaining 
above 1000 °C corresponds to the formation of 
thermally stable metal oxide in respective systems. 
 
Table 1 — Elemental analyses and physical properties of NTEMNC metal complexes 
Empirical formula Yield (%) Colour Analyses found (calc) % Λm (Ω
- 1cm2mol-1) 
C H N Metal 






























Fig. 1 — UV-vis spectrum of (a) Cu(II)-NTEMNC, (b) Ni(II)-NTEMNC, and, (c) Co(II)-NTEMNC. 
 





ESR spectrum of Cu(II) complex (Fig. S14) 
recorded at 77 K gave g║ and g┴ values as 2.1196 and 
2.0015 respectively. The trend g║ > g┴ is characteristic 
for axially elongated octahedral geometry and 
presence of unpaired electron in dx2-y2 orbital.  
 
Magnetic susceptibilities measurements 
The calculated magnetic moments of Cu(II), Ni(II) 
and Co(II) complexes are 1.91, 2.73 and 3.81 BM 
respectively. This reveals the paramagnetic behavior 
of all complexes, in accordance with electronic 
properties. A tentative structure is assigned (Fig. 3) 
for the metal complexes on the basis of the 
aforementioned results. 
 
Molecular docking studies 
Molecular docking technique is an important tool to 
understand the interaction of novel compounds and 
their metal complexes with DNA in order to 
understand their potential to bind at receptor sites of 
target nucleic acids53. In the present investigation, 
molecular docking studies of newly synthesized 
ligand (NTEMNC) and its Cu(II), Ni(II) and Co(II) 
metal complexes with DNA duplex of sequence 
(AGACGTCT)2 (PDB ID: 1N37) were performed to 
predict the binding mode (Fig. 4(a)-(f)). Docking of 
compounds into DNA mainly showed hydrogen 
bonding interaction with G5 nucleotide. The 
molecular structure of title compounds in respective 
systems, is placed at larger cavity in between base 
pairs of target DNA helix, and then subjected to 
structural optimization. The optimized structure is then 
docked for the formation of adduct with the DNA 
helix. The resultant dock score and the data for type of 
interactions in a particular system are informative to 
predict the stability of docked molecule in host DNA. 
It has been observed that naphthyridinone group in free 
ligand is intercalated and consists of hydrogen bonding 
and π-π interactions while in Ni(II) and Cu(II) 
complexes, metal chelate part is intercalated, showing 
same type of interactions. The dock score provided in 
Table 2 represents better binding affinity of Ni(II) and 
Cu(II) complexes than Co(II) complex and free ligand. 
The inhibition constant which is high for free ligand 
and low for Ni(II) complex indicates lesser binding 
affinity with former and more binding affinity with 
latter. These binding affinities are in accordance to the 
dock score and thus the order of binding is envisaged 
as; Ni(II) > Cu(II) > Co(II) > NTEMNC. As the 
inhibition constant is very high for free ligand it can be 
concluded that even though there is an intercalation of 
moieties between base pairs of DNA, the binding 
affinity is far less when compared to that in complexes.  
 
in vitro Biological studies 
 
Antimicrobial activity 
The antibacterial and antifungal activity results 
indicate    that    the   newly    synthesized   hydrazone  
 
 




Fig. 3 — Tentative structure of complex M: Cu(II), Ni(II) 
and Co(II). 
 




(NTEMNC) and its Cu(II), Ni(II) and Co(II) 
complexes showed good activity against bacteria and 
fungi species respectively. The zone inhibition 
diameter (in cm) obtained against each 
microorganism and the relevant data are presented in 
Supplementary Data, Table S1 and Fig. S15. It has 
been observed that zone inhibition diameter increased 
with the increase in concentration of a test compound 
signifying the importance of concentration and its 
effect54. The more pronounced activity of complexes 
of NTEMNC compared to the unbound NTEMNC is 
because of relatively more lipophilicity of complexes 
which enables them to pass through the cell 
membrane with more ease55. The varying degree of 
inhibitory effects of different complexes on the 
growth of bacterial and fungal strains may be due to 
the effect of the respective metal ion on the cell 
metabolism. Interestingly, the synthesized title 
compound NTEMNC and its metal complexes have 
shown enhanced antimicrobial activity as compared to 
pure nalidixic acid, which is a clinically prominent 
antibiotic used in the treatment of urinary tract 
infections56.  
 
Cytotoxic studies  
The cytotoxicity of synthesized Cu(II), Ni(II) and 
Co(II) metal complexes and corresponding 
hydrazone (NTEMNC) against HeLa (human 
cervical cancer cell line) and A549 (human lung 
tumor cell line) cell lines were evaluated by MTT 
assay. Experiments revealed that the cytotoxicity of 
the compounds was found to be concentration 
dependent (Fig. S16) where increase in the 
concentration of compounds exhibited a decrease in 
cell viability indicating enhanced cytotoxicity. The 
IC50 values (Table S2) for compounds reveal that the 
hydrazone and its complexes exhibits antitumor 
activity against HeLa and A549 cell lines. The 
microscopic images of cells after treating HeLa cell 
lines with compounds are presented in Fig. S17. 
Morphological changes are obvious in the images of 
cells inferring the pronounced effect of the 
compounds under investigation. 
 
DNA binding studies 
 
Absorption studies 
The absorption spectra of the complexes Cu(II), 
Ni(II) and Co(II) in the presence and absence of  
CT-DNA are shown in Fig. 5. With increasing 
concentration of DNA, the absorption spectra of the 
complexes exhibited gradual decrease in absorption 
(hypochromism) and shift in the wavelength 
 
Fig. 4 — Dockpose of (a) Ni(II)-NTEMNC and (b) NTEMNC at 
intercalation site of DNA. Dock pose of Ni(II) complex showing
hydrogen bond interaction with G5 of DNA strand and
π- π stacking interaction with G5, T6, A11, C12, and G13 bases:
(c) full view and (d) enlarged view. Dock pose of NTEMNC
showing hydrogen bond interaction with G5 of DNA strand and
π – π interaction with G5, C12 and G13 bases: (e) full view and 
(f) enlarged view. 
 
Table 2 — Dock score and calculated inhibition constant of 
NTEMNC and its metal complexes 
Molecule Dock score (kcal/mol) 





NTEMNC -5.96 42.74 
Cu(II) -8.63 0.468 
Ni(II) -9.38 0.133 
Co(II) -6.84 9.66 
 




(bathochromism/red shift), due to the intercalative 
mode of interaction involving a strong π-π* stacking 
interaction between the aromatic chromophore and 
the base pairs of DNA. 
In order to compare quantitatively the binding 
strength of the complexes, the intrinsic binding 
constants Kb of the complexes with DNA were 
obtained by monitoring the changes in absorbance at 
395 nm for Cu(II), 316 nm for Ni(II) and 343 nm for 
Co(II) with increasing concentration of DNA using 
the eqn (1). 
Binding constant Kb is given by the ratio of slope 
to intercept. From the absorption data, the binding 
constants (Kb) for Cu(II), Co(II) and Ni(II)  
complexes are 5.3± 0.01×104 M-1, 4.4± 0.02×104 M-1 
and 7.0±0.01×104 M-1 respectively. These results 
indicate that the binding affinity of all metal 
complexes with CT-DNA is moderate in comparison 
with strong intercalators 57. However the DNA 
binding affinities of these complexes follow the order: 
Ni(II) > Cu(II) > Co(II).  
 
Fluorescence studies 
In order to further investigate the interaction mode 
of Cu(II), Ni(II) and Co(II) complexes with CT-DNA, 
a competitive binding experiment using ethidium 
bromide (EB) as a probe was carried out. EB is a 
conjugate planar molecule with very weak 
fluorescence intensity due to fluorescence quenching 
of the free EB by solvent molecules but it is greatly 
enhanced when EB is specifically intercalated into the 
adjacent base pairs of double stranded DNA. The 
enhanced fluorescence can be quenched upon the 
addition of the second molecule which could replace 
the bound EB or break the secondary structure of the 
DNA. Upon the addition of complexes Cu(II), Ni(II) 
and Co(II) to CT-DNA pretreated with EB, a 
significant reduction in the emission intensity (Fig. 6) 
was observed, indicating competitive intercalation of 
complexes and thus effecting the equilibrium for the 
formation of [DNA-EB] complex. As the studied 
metal complexes have the potential to act as 
intercalators, the concentration of DNA-ethidium 
bromide decreases and thus results in quenching of 
fluorescence. The classical Stern-Volmer constant 
(Ksv), binding constant (Kb) values and number of 
binding sites (n) of the metal complexes are 
calculated using eqns (2) and (3) are in the order of 





Fig. 5 — Absorption spectra of complexes (a) Cu(II), (b) Co(II), and, (c) Ni(II) in the absence (dotted line) and presence (solid line) of 
increasing concentration of CT-DNA in Tris-HCl buffer. Arrow (↓) shows the hypochromic and bathochromic shift upon increase of the 




Fig. 6 — Emission spectra of the DNA-ethidium bromide (EB) with (a) Cu (II), (b) Ni(II), and, (c) Co(II), arrows show the emission 
intensity changes upon increasing concentration of the compounds [Inset: Scatchard equation plots (I), Stern volumer equation plots (II)].
 




both absorption and fluorescent titrations are in good 
agreement (Table 3). 
The docking studies discussed earlier also indicated 
a lower value of inhibition constant (Ki) and more 
negative free energy value for Ni(II) complex, 
suggesting its greater affinity in binding with DNA 
compared to other two complexes and hence one can 
predict that the experimental results obtained from 
absorption and fluorescence studies are corroborative 
with the predictions from computational studies. 
 
Conclusions  
Novel potential chelating agent and its binary 
Cu(II), Ni(II) and Co(II) metal complexes were 
synthesized and characterized. DNA docking studies 
revealed intercalative mode of binding of title ligand 
and its complexes involving hydrogen bonding and  
π- π interactions.  
Absorption and fluorescence studies revealed the 
effective binding of title metal complexes with  
CT-DNA base pairs. The antitumor and antimicrobial 
activity of the compounds under investigation followed 
the order: Ni(II) > Cu(II)> Co(II) > NTEMNC. 
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